Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:23 am Purchase | 2022-12-31 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Biotechnology Master Fund, Ltd. | 1,704,000 8.230% | 579,579 (+51.54%) | Filing History |
| 2023-02-14 08:23 am Purchase | 2022-12-31 | 13G | Agenus Inc. AGEN | Deep Track Biotechnology Master Fund, Ltd. | 1,375,650 8.860% | 599,723 (+77.29%) | Filing History |
| 2023-02-14 08:21 am Purchase | 2022-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS | Deep Track Biotechnology Master Fund, Ltd. | 3,952,000 9.660% | 1,537,083 (+63.65%) | Filing History |
| 2023-02-03 4:31 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | Deep Track Biotechnology Master Fund, Ltd. | 7,940,346 7.610% | 7,940,346 (New Position) | Filing History |
| 2023-01-13 4:14 pm Purchase | 2023-01-06 | 13G | Geron Corporation GERN | Deep Track Biotechnology Master Fund, Ltd. | 24,022,883 5.350% | 24,022,883 (New Position) | Filing History |
| 2022-12-22 4:02 pm Purchase | 2022-12-15 | 13G | Astria Therapeutics, Inc. ATXS | Deep Track Biotechnology Master Fund, Ltd. | 1,816,531 7.320% | 1,816,531 (New Position) | Filing History |
| 2022-12-19 4:11 pm Purchase | 2022-12-09 | 13G | Autolus Therapeutics plc AUTL | Deep Track Biotechnology Master Fund, Ltd. | 15,000,000 9.030% | 15,000,000 (New Position) | Filing History |
| 2022-10-28 4:10 pm Purchase | 2022-10-18 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Deep Track Biotechnology Master Fund, Ltd. | 7,841,570 5.530% | 7,841,570 (New Position) | Filing History |
| 2022-10-21 4:01 pm Purchase | 2022-10-13 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Biotechnology Master Fund, Ltd. | 2,481,000 8.250% | 2,481,000 (New Position) | Filing History |
| 2022-10-20 4:00 pm Purchase | 2022-10-10 | 13G | Immunic, Inc. IMUX | Deep Track Biotechnology Master Fund, Ltd. | 4,022,989 9.290% | 4,022,989 (New Position) | Filing History |
| 2022-10-07 4:02 pm Purchase | 2022-09-29 | 13G | Valneva SE VALN | Deep Track Biotechnology Master Fund, Ltd. | 10,513,265 7.600% | 10,513,265 (New Position) | Filing History |
| 2022-10-03 4:37 pm Purchase | 2022-09-23 | 13G | Albireo Pharma, Inc. ALBO | Deep Track Biotechnology Master Fund, Ltd. | 1,124,421 5.460% | 1,124,421 (New Position) | Filing History |
| 2022-09-30 4:03 pm Purchase | 2022-09-22 | 13G | Allakos Inc. ALLK | Deep Track Biotechnology Master Fund, Ltd. | 4,518,575 5.330% | 4,518,575 (New Position) | Filing History |
| 2022-09-23 4:11 pm Purchase | 2022-09-14 | 13G | Edgewise Therapeutics, Inc. EWTX | Deep Track Biotechnology Master Fund, Ltd. | 3,374,394 5.340% | 3,374,394 (New Position) | Filing History |
| 2022-09-19 4:07 pm Purchase | 2022-09-16 | 13G | Syros Pharmaceuticals, Inc. SYRS | Deep Track Biotechnology Master Fund, Ltd. | 699,281 9.990% | 699,281 (New Position) | Filing History |
| 2022-09-16 4:08 pm Purchase | 2022-09-06 | 13G | IVERIC bio, Inc. ISEE | Deep Track Biotechnology Master Fund, Ltd. | 9,000,000 7.620% | 9,000,000 (New Position) | Filing History |
| 2022-09-12 4:19 pm Purchase | 2022-09-02 | 13G | Ardelyx, Inc. ARDX | Deep Track Biotechnology Master Fund, Ltd. | 14,252,831 8.450% | 14,252,831 (New Position) | Filing History |
| 2022-08-22 4:16 pm Purchase | 2022-08-12 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Biotechnology Master Fund, Ltd. | 3,684,619 9.990% | 3,684,619 (New Position) | Filing History |
| 2022-08-22 4:13 pm Purchase | 2022-08-12 | 13G | Silence Therapeutics plc SLN | Deep Track Biotechnology Master Fund, Ltd. | 5,854,740 5.440% | 5,854,740 (New Position) | Filing History |
| 2022-08-19 4:03 pm Purchase | 2022-08-09 | 13G | Heron Therapeutics, Inc. HRTX | Deep Track Biotechnology Master Fund, Ltd. | 12,232,267 9.990% | 12,232,267 (New Position) | Filing History |